#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14318	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2230	638.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1454	1454	C	829	C,T	780,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25752	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3571	719.4	0	.	n	.	0	T695C	SNP	695	695	T	1050	1050	C	752	C	714	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25752	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3571	719.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1692	1692	A	870	A,G	816,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25752	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3571	719.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2326	2326	C	829	C,T	787,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25752	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3571	719.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2400	2400	A	844	A	801	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25752	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3571	719.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2952	2952	C	785	C	735	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2070	folP	852	852	100.0	folP.l15.c4.ctg.1	1493	138.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1019	1021	AGC	199;197;196	A;G;C	192;190;191	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4898	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3320	147.1	1	SNP	p	S91F	0	.	.	271	273	TCC	576	578	TCC	157;155;157	T;C;C	147;147;146	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4898	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3320	147.1	1	SNP	p	D95N	0	.	.	283	285	GAC	588	590	GAC	161;161;162	G;A;C	154;152;155	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4898	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3320	147.1	1	SNP	p	D95G	0	.	.	283	285	GAC	588	590	GAC	161;161;162	G;A;C	154;152;155	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1556	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1274	121.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	449	451	ACC	188;192;190	A;C;C	178;184;184	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1556	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1274	121.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	464	466	CAC	201;204;205	C;A,G;C	192;190,1;196	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1556	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1274	121.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	647	649	CAC	212;211;209	C,T;A,C;C	201,1;199,1;201	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1556	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1274	121.9	1	SNP	p	G45D	0	.	.	133	135	GGC	467	469	GGC	206;209;209	G;G;C	194;197;198	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	848	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	990	85.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	171.2	1	SNP	p	D86N	0	.	.	256	258	GAC	568	570	GAC	192;193;195	G;A;C	182;179;184	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	171.2	1	SNP	p	S87I	0	.	.	259	261	AGT	571	573	AGT	193;191;190	A;G;T	179;180;175	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	171.2	1	SNP	p	S87R	0	.	.	259	261	AGT	571	573	AGT	193;191;190	A;G;T	179;180;175	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	171.2	1	SNP	p	S87W	0	.	.	259	261	AGT	571	573	AGT	193;191;190	A;G;T	179;180;175	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4986	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	171.2	1	SNP	p	S88P	0	.	.	262	264	TCC	574	576	TCC	192;196;200	T;C;C	178;183;188	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4188	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2657	157.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1540	1542	GGC	222;216;215	G;G;C	210;204;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1216	1218	GCA	195;196;201	G;C;A	187;187;194	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1219	1221	ATC	199;203;207	A;T;C	189;194;199	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1231	1233	GTG	212;215;216	G;T;G	201;204;206	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1231	1233	GTG	212;215;216	G;T;G	201;204;206	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1735	1737	ACC	203;202;199	A;C;C	186;186;187	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1789	1791	GCG	192;191;190	G;C;G	171;159;160	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1789	1791	GCG	192;191;190	G;C;G	171;159;160	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1912	1914	GGC	175;174;176	G;G;C	160;158;161	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1921	1923	GGC	163;158;157	G;G;C,A	150;146;144,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3852	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2417	158.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1939	1941	CCG	126;126;123	C,G;C;G	95,1;98;92	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5590	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3010	184.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1580	1582	CTG	176;177;178	C;T;G	165;167;172	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2254	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1914	117.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	656	656	C	126	C,T	114,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	482	484	GTT	221;220;221	G;T,A;T	205;204,1;207	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	0	.	p	.	0	I75V	NONSYN	223	225	ATT	572	574	GTT	211;211;212	G;T;T	189;183;187	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	0	.	p	.	0	S89T	NONSYN	265	267	AGC	614	616	ACC	201;203;204	A;C,G;C	172;182,1;188	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	0	.	p	.	0	I98V	NONSYN	292	294	ATC	641	643	GTC	210;210;209	G,A,C;T;C	191,1,1;189;196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1103	1105	GAA	229;227;223	G;A,G;A	217;216,1;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	1	SNP	p	G120K	1	.	.	358	360	AAG	707	709	AAG	195;194;190	A;A;G	184;182;177	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	1	SNP	p	A121N	1	.	.	361	363	AAC	710	712	AAC	189;191;190	A;A;C	178;179;178	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2658	porB1b	1038	1038	99.42	porB1b.l6.c4.ctg.1	1604	165.1	1	SNP	p	N121D	0	.	.	361	363	AAC	710	712	AAC	189;191;190	A;A;C	178;179;178	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9760	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4924	197.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2018	2020	AAT	193;193;196	A,C;A;T	183,1;185;186	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1024	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1076	94.5	1	SNP	p	V57M	1	.	.	169	171	ATG	616	618	ATG	209;210;212	A;T;G	201;201;203	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
